Flexeril (cyclobenzaprine) works by acting on the central nervous system to reduce muscle spasm signals before they reach your muscles. Rather than relaxing muscles directly, it interrupts the cycle of spasm and pain at the level of the brainstem and spinal cord, calming overactive nerve signals that keep injured muscles locked in contraction. It’s approved specifically as a short-term add-on to rest and physical therapy for acute, painful musculoskeletal conditions.
Where It Acts in the Nervous System
When you strain a muscle or injure soft tissue, your nervous system can overreact. Motor neurons (the nerves controlling muscle contraction) fire excessively, creating a painful feedback loop: the muscle spasms, the spasm causes more pain, and the pain triggers more spasm. Cyclobenzaprine breaks this loop by reducing tonic motor activity in the brainstem, which is the command center that regulates muscle tone throughout your body. It dials down the signals traveling from the brain and spinal cord to the affected muscles, allowing them to relax without directly numbing or paralyzing anything.
This is why Flexeril is called a “centrally acting” muscle relaxant. It doesn’t work at the muscle itself. It works upstream, in the brain and spinal cord, to quiet the nervous system’s overreaction to injury. The result is less involuntary tightness, less pain from sustained contraction, and an easier time resting or participating in physical therapy.
Why It Resembles an Antidepressant
Cyclobenzaprine is structurally almost identical to amitriptyline, a tricyclic antidepressant. The two molecules are so similar that standard toxicology screens often misidentify cyclobenzaprine as a tricyclic antidepressant, and older lab methods could barely distinguish them. Only more advanced techniques, like comparing how the molecules absorb ultraviolet light, reliably tell them apart.
This structural kinship explains much of Flexeril’s side effect profile. Like tricyclic antidepressants, it blocks certain chemical messengers in the nervous system, particularly acetylcholine. That’s why the most common complaints are dry mouth, drowsiness, and dizziness. These aren’t random side effects. They’re direct consequences of the same brain chemistry that makes the drug effective at calming overactive nerve signals. In clinical trials, roughly 54% of patients on the lower dose and 62% on the higher dose reported at least one side effect, compared to about 35% on placebo.
How Quickly It Works and How Long It Lasts
The immediate-release tablet is designed to be taken three times a day. An extended-release version delivers the same active ingredient in a single daily dose, reaching peak blood levels around 7 hours after you take it and maintaining a steady concentration throughout the day. At steady state, the extended-release form has a half-life of about 35 hours, meaning the drug clears your system gradually over several days after you stop taking it.
That long half-life is one reason drowsiness can linger, especially in the first few days. Your body accumulates the drug over roughly a week of regular use before reaching a stable level. If you feel particularly sedated early on, it often improves as your body adjusts, though some people remain drowsy for the duration of treatment.
The 5 mg vs. 10 mg Question
Two placebo-controlled trials found that the lower dose (5 mg three times daily) provided the same pain relief and muscle spasm reduction as the higher dose (10 mg three times daily). Both doses significantly outperformed placebo by day 7. The practical difference was in side effects: the 5 mg dose caused less sedation. This is why many prescribers start at the lower dose, since you get the same benefit with a better chance of staying alert enough to function during the day.
Why It’s Only for Short-Term Use
Flexeril is meant to be used for two to three weeks at most. The FDA label is explicit: there’s no good evidence that it works beyond that window, and the muscle spasms it treats are typically short-lived conditions that resolve on their own with rest and physical therapy. The drug is a bridge to get you through the worst of an acute flare, not a long-term solution for chronic muscle pain.
This time limit also reflects the side effect burden. The anticholinergic effects (dry mouth, constipation, blurred vision, urinary retention) become more problematic the longer you take the drug. Tolerance to the sedating effects can develop, but the other side effects tend to persist.
Risks for Older Adults
Cyclobenzaprine is on the Beers Criteria list of medications that older adults should avoid. This is a strong recommendation backed by moderate evidence. The concerns are twofold: the drug’s anticholinergic activity is more burdensome in aging bodies that are already more sensitive to these effects, and the long half-life means the drug accumulates to higher levels in people whose livers and kidneys process it more slowly. The practical risks include excessive sedation, confusion, falls, and urinary retention.
Dangerous Drug Interactions
The most critical interaction is with MAO inhibitors, a class of medications used for depression and Parkinson’s disease. Combining Flexeril with an MAO inhibitor, or taking Flexeril within 14 days of stopping one, can trigger a life-threatening reaction involving dangerously high body temperature, seizures, and death. This isn’t a theoretical warning. Fatal cases have been documented.
Flexeril can also contribute to serotonin syndrome when combined with other drugs that raise serotonin levels. Symptoms include confusion, agitation, rapid heart rate, unstable blood pressure, muscle rigidity, tremor, and gastrointestinal distress like nausea and diarrhea. Because so many common medications affect serotonin (including certain antidepressants, migraine drugs, and pain medications), it’s important that anyone prescribing Flexeril knows your full medication list.
Alcohol and other central nervous system depressants amplify Flexeril’s sedating effects. Combining them increases the risk of excessive drowsiness, impaired coordination, and slowed breathing. This interaction is especially relevant because people often reach for a drink to cope with the same back pain or neck strain that prompted the prescription in the first place.